Gabriel Odom to Humans
This is a "connection" page, showing publications Gabriel Odom has written about Humans.
Connection Strength
0.249
-
Odom GJ, Brandt L, Marker A, Giorgi S, Jainarain G, Schwartz HA, Au L, Castro C. From Clinical Trials to Real-World Impact: Introducing a Computational Framework to Detect Endpoint Bias in Opioid Use Disorder Research. Drug Alcohol Rev. 2026 01; 45(1):e70085.
Score: 0.043
-
Ca?izares C, G?mez-Maquet Y, Ferro E, Torres CA, Agudelo DM, Odom G. Using tree-based models to identify factors contributing to trait negative affect in adults. BMC Psychol. 2025 Feb 01; 13(1):92.
Score: 0.040
-
Odom GJ, Brandt L, Castro C, Luo SX, Feaster DJ, Balise RR. Capturing drug use patterns at a glance: An n-ary word sufficient statistic for repeated univariate categorical values. PLoS One. 2023; 18(9):e0291248.
Score: 0.036
-
Williams R, Bursac Z, Trepka MJ, Odom GJ. Lessons Learned From Miami-Dade County's COVID-19 Epidemic: Making Surveillance Data Accessible for Policy Makers. J Public Health Manag Pract. 2021 May-Jun 01; 27(3):310-317.
Score: 0.031
-
Odom GJ, Ban Y, Colaprico A, Liu L, Silva TC, Sun X, Pico AR, Zhang B, Wang L, Chen X. PathwayPCA: an R/Bioconductor Package for Pathway Based Integrative Analysis of Multi-Omics Data. Proteomics. 2020 11; 20(21-22):e1900409.
Score: 0.029
-
Balise RR, Grealis K, Brandt L, Luo SX, Odom G, Jean-Baptiste G, Feaster DJ. Applying machine learning in predicting medication treatment outcomes for opioid use disorder. J Subst Use Addict Treat. 2026 Mar; 182:209847.
Score: 0.011
-
Balise RR, Hu MC, Calderon AR, Odom GJ, Brandt L, Luo SX, Feaster DJ. Data cleaning and harmonization of clinical trial data: Medication-assisted treatment for opioid use disorder. PLoS One. 2024; 19(11):e0312695.
Score: 0.010
-
Brandt L, Odom GJ, Hu MC, Castro C, Balise RR. Empirically contrasting urine drug screening-based opioid use disorder treatment outcome definitions. Addiction. 2024 07; 119(7):1289-1300.
Score: 0.009
-
Luo SX, Feaster DJ, Liu Y, Balise RR, Hu MC, Bouzoubaa L, Odom GJ, Brandt L, Pan Y, Hser YI, VanVeldhuisen P, Castillo F, Calderon AR, Rotrosen J, Saxon AJ, Weiss RD, Wall M, Nunes EV. Individual-Level Risk Prediction of Return to Use During Opioid Use Disorder Treatment. JAMA Psychiatry. 2024 01 01; 81(1):45-56.
Score: 0.009
-
Brandt L, Hu MC, Liu Y, Castillo F, Odom GJ, Balise RR, Feaster DJ, Nunes EV, Luo SX. Risk of Experiencing an Overdose Event for Patients Undergoing Treatment With Medication for Opioid Use Disorder. Am J Psychiatry. 2023 05 01; 180(5):386-394.
Score: 0.009
-
Colaprico A, Olsen C, Bailey MH, Odom GJ, Terkelsen T, Silva TC, Olsen AV, Cantini L, Zinovyev A, Barillot E, Noushmehr H, Bertoli G, Castiglioni I, Cava C, Bontempi G, Chen XS, Papaleo E. Interpreting pathways to discover cancer driver genes with Moonlight. Nat Commun. 2020 01 03; 11(1):69.
Score: 0.007
-
Mallik S, Odom GJ, Gao Z, Gomez L, Chen X, Wang L. An evaluation of supervised methods for identifying differentially methylated regions in Illumina methylation arrays. Brief Bioinform. 2019 11 27; 20(6):2224-2235.
Score: 0.007
-
Gomez L, Odom GJ, Young JI, Martin ER, Liu L, Chen X, Griswold AJ, Gao Z, Zhang L, Wang L. coMethDMR: accurate identification of co-methylated and differentially methylated regions in epigenome-wide association studies with continuous phenotypes. Nucleic Acids Res. 2019 09 26; 47(17):e98.
Score: 0.007